Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05284656
PHASE3

Effect of Folic Acid and/or Pentoxifylline on Patients With Chronic Kidney Disease

Sponsor: Al-Azhar University

View on ClinicalTrials.gov

Summary

The aim of this study is to evaluate the effect of administration of folic acid and /or pentoxifylline on patients with chronic kidney disease (CKD).

Official title: The Potential Nephro-protective Effect of Folic Acid and/or Pentoxifylline on Patients With Chronic Kidney Disease

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

80

Start Date

2022-01-08

Completion Date

2026-12-19

Last Updated

2025-06-11

Healthy Volunteers

No

Interventions

DRUG

combination of Pentoxifylline 400 MG and Folic Acid

drugs used to delay progression of chronic kidney disease

DRUG

folic acid

drugs used to delay progression of chronic kidney disease

DRUG

Pentoxifylline 400 MG

drugs used to delay progression of chronic kidney disease

Locations (1)

Al Azhar University

Cairo, Egypt